Follicular lymphoma is a type of systemic lymphomas which constitutes approximately 30-35% all Non-Hodgkin lymphomas. It typically presents itself in the form generalized lymphadenopathy, hepatomegaly, splenomegaly and bone marrow involvement. Cutaneous involvement follicular generally appears as skin-coloured to red, violaceous papules or nodules most commonly involving scalp, trunk head&n...

Lymphocytopenia is a poor prognostic marker in initial staging of non- Hodgkin lymphomas (below 1.0 x 10(9)/l) and Hodgkin lymphoma (below 0.6 x 10(9)/l) and in relapsed diffuse large B cell lymphoma. Early lymphocyte recovery > or =0.5 x 10(9)/l after autologous and allogeneic stem cell transplantation is a significant predictor of tumor control and survival in lymphomas. Natural killer cells ...

primary pancreatic lymphoma is a rare extranodal manifestation of any histopathologic subtype of b cell non-hodgkin's lymphoma that predominantly involves the pancreas. it comprises less than 0.2% of pancreatic malignancies and less than 0.7% of non-hodgkin's lymphomas. this lymphoma is almost never suspected clinically. it is usually diagnosed by surgical exploration for suspected ad...

Primary cutaneous lymphomas (PCLs) are defined as non-Hodgkin lymphomas that present in the skin with no evidence of extracutaneous disease at the time of diagnosis. After the gastrointestinal lymphomas, PCLs are the second most common group of extranodal non-Hodgkin lymphomas with an estimated annual incidence of 1/100 000. PCL must be distinguished from nodal or systemic malignant lymphomas i...

After infections, malignancies, lymphomas especially, are the second most frequent cause of death in patients with inborn errors immunity. Factors predetermining appearance and aggressiveness include gene defects, defects immune surveillance regulation as well infections oncogenic viruses. Aggressive non-Hodgkin lymphomas, mostly diffuse large B-cell Bukit subtypes predominant deoxyribonucleic ...

INTRODUCTION Allogeneic hematopoietic stem cell transplantation offers the opportunity for extended survival in patients with Hodgkin's and non-Hodgkin lymphomas who relapsed after, or were deemed ineligible for, autologous transplantation. This study reports the cumulative experience of a single center over the past 14 years aiming to define the impact of patient, disease, and transplant-relat...

OBJECTIVES Non-Hodgkin lymphomas are malignant neoplastic proliferations of the immune system that can manifest as nodal or extranodal lymphomas. The aim of this study was to retrospectively investigate the site of occurrence of lymphomas in the head and neck area and to analyze the typical symptoms of patients who presented at an oral and maxillofacial surgical department. MATERIAL AND METHO...

Programmed death 1 (PD-1) protein and its ligands, PD-L1 are two proteins that have been widely studied in many solid tumours. However, only limited observations were made lymphomas, which mainly Hodgkin lymphomas. We aimed to evaluate the expressions of PD-1 tumour microenvironment cells primary extranodal non-Hodgkin lymphoma (peNHL). A cross-sectional study using 87 archived formalin-fixed p...

Primary cutaneous B-cell lymphomas are non-Hodgkin presenting only in the skin and represent 25% of all primary lymphomas. Based on their clinical behavior, they classified into indolent intermediate forms. Treatment forms includes surgery, radiotherapy, and, extensive disease, rituximab. We report a case 57-year-old woman with single nodule left arm treated surgical excision 5-mm security marg...